(Q35829744)

10 August 2017

Nevirapine-Based Antiretroviral Therapy Impacts Artesunate and Dihydroartemisinin Disposition in HIV-Infected Nigerian Adults (English)

1 reference

10 August 2017

anti-retroviral agent

0 references

0 references

1 reference

Olusegun O. Akinyinka

Olusegun O Akinyinka

13

0 references

Qing Ma

Qing Ma

3

0 references

Robert L. Murphy

Robert L Murphy

12

0 references

Babafemi Taiwo

6

Babafemi Taiwo

1 reference

10 August 2017

Fatai A Fehintola

1

1 reference

10 August 2017

Kimberly K Scarsi

2

1 reference

10 August 2017

Sunil Parikh

4

1 reference

10 August 2017

Gene D Morse

5

1 reference

10 August 2017

Ibrahim Tope Akinola

7

1 reference

10 August 2017

Isaac F Adewole

8

1 reference

10 August 2017

Niklas Lindegardh

9

1 reference

10 August 2017

Aphiradee Phakderaj

10

1 reference

10 August 2017

Oladosu Ojengbede

11

1 reference

10 August 2017

Francesca T Aweeka

14

1 reference

10 August 2017

5 March 2012

1 reference

AIDS Research and Treatment

10 August 2017

1 reference

10 August 2017

2012

1 reference

10 August 2017

703604

1 reference

Creative Commons Attribution 3.0 Unported

10 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Interaction between artemether-lumefantrine and nevirapine-based antiretroviral therapy in HIV-1-infected patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Differences in the pharmacokinetics of protease inhibitors between healthy volunteers and HIV-infected persons

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

A liquid chromatographic-tandem mass spectrometric method for determination of artesunate and its metabolite dihydroartemisinin in human plasma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Antimalarial bioavailability and disposition of artesunate in acute falciparum malaria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Population pharmacokinetics and therapeutic response of CGP 56697 (artemether + benflumetol) in malaria patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults.

27 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F703604

Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F703604

Pharmacokinetics of nevirapine: initial single-rising-dose study in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F703604

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F703604

Drug interactions should be evaluated in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F703604

The evaluation of radiolabeled artesunate on tissue distribution in rats and protein binding in humans.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria

24 September 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

24 September 2018

https://api.crossref.org/works/10.1155%2F2012%2F703604

Disposition and biotransformation of the antiretroviral drug nevirapine in humans.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

Pharmacokinetics of artemisinin and artesunate after oral administration in healthy volunteers.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303559

24 September 2018

Identifiers

DOI

10.1155/2012/703604

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

22500218

1 reference